Table 1 Comparisons of laboratory parameters and clinical data in patients with mild and moderately severe to severe hypertriglyceridemia-induced pancreatitis

Sex

0.141

 Male

193

60 (85.7)

133 (77.3)

 Female

49

10 (14.3)

39 (22.7)

Age (years)

40 (34–47)

42 (35–49)

39 (33–46)

0.101

CRP (mg/L)

< 0.001

21

  < 90

91

43 (69.4)

48 (30.2)

  ≥ 90

130

19 (30.6)

111 (69.8)

Albumin (g/L)

36.54 ± 6.56

40.38 ± 4.89

34.98 ± 6.52

< 0.001

  < 35

103

11 (15.7)

92 (53.5)

< 0.001

  ≥ 35

139

59 (84.3)

80 (46.5)

Triglyceride (mmol/L)

12.74 (8.18–25.12)

10.64 (6.69–21.50)

13.34 (9.45–26.10)

0.008

12

High (< 22.4 mmol/L)

163

50 (76.9)

113 (68.5)

0.205

Very high (≥22.4 mmol/L)

67

15 (23.1)

52 (31.5)

Amylase (U/L)

121 (67–269)

90 (51–216)

133 (73–314)

0.027

Lipase (U/L)

234 (112–612)

151 (84–404)

263 (126–664)

0.003

13

Total cholesterol (mmol/L)

8.42 (6.31–12.19)

7.24 (5.95–10.27)

9.11 (6.53–13.14)

0.006

HDL-C (mmol/L)

0.60 (0.46–0.79)

0.76 (0.62–0.87)

0.56 (0.43–0.70)

< 0.001

1

LDL-C (mmol/L)

2.06 (1.59–1.92)

1.96 (1.57–2.46)

2.13 (1.59–2.97)

0.231

1

Non-HDL-C (mmol/L)

8.04 (5.47–11.53)

6.48 (5.13–9.52)

8.50 (5.80–12.56)

0.004

1

ApoA-I (g/L)

0.84 (0.67–1.09)

1.10 (0.84–1.30)

0.78 (0.66–0.97)

< 0.001

7

ApoB (g/L)

0.81 (0.49–1.29)

0.80 (0.48–1.17)

0.81 (0.48–1.35)

0.294

36

Lipoprotein (mg/L)

48.5 (26.8–115.3)

48.0 (30.0–86.0)

49.0 (23.0–129.0)

0.830

8

Length of hospital stay (days)

13 (9–20)

9 (7–11.5)

17 (11–21)

< 0.001

  < 14

131

61 (88.4)

70 (40.7)

< 0.001

  ≥ 14

110

8 (11.6)

102 (59.3)